Another £1B+ pulled in London in an active month including eight mega ($100M+) deals.
Today, I take a look at the state of venture capital and angel funding during October 2021 in London. Analyzing some publicly available data from our friends at CrunchBase, we break down the aggregate statistics for all funding deals by stage of funding (Early-stage [Angel, Pre-Seed, Seed], Series A, Series B, and Late-Stage [Series C+]) including mention of notable rounds. This analysis does not include debt financings, real estate, and biotechnology deals to maintain a focus on conventional tech-enabled startups.
NowRx is disrupting the $480B retail pharmacy industry with unheard of personalized service and free same-day pharmacy delivery. The company uses its “QuickFill” proprietary pharmacy software and robotics to automate prescription dispensing and reduce common service failures that result in bad experiences for customers (insurance errors, out-of-stock, etc.). Oh, and they operate at a fraction of the cost of major retail chains – talk about efficiency! In 2020, the company saw revenue jump 90% YoY and this year they’re on pace to surpass more than $22M in revenue. With their newest telehealth product growing 73% MoM and a share price that has increased by 1,650% since 2016 – this is an investment you don’t want to miss out on. Get in on this rapidly growing startup and learn how you can invest today
The average early-stage round in London for December was £3.5M Tweet This
The median early-stage round in London for December was £3.1M Tweet This
£140.6M was invested across early stages rounds in London in December Tweet This
NowRx is disrupting the $480B retail pharmacy industry with unheard of personalized service and free same-day pharmacy delivery.
The company uses its “QuickFill” proprietary pharmacy software and robotics to automate prescription dispensing and reduce common service failures that result in bad experiences for customers (insurance errors, out-of-stock, etc.).
Oh, and they operate at a fraction of the cost of major retail chains – talk about efficiency!
In 2020, the company saw revenue jump 90% YoY and this year they’re on pace to surpass more than $22M in revenue. With their newest telehealth product growing 73% MoM and a share price that has increased by 1,650% since 2016 – this is an investment you don’t want to miss out on.
Get in on this rapidly growing startup and learn how you can invest today
The average Series A round in London for December was £13.3M Tweet This
The median Series A round in London for December was £7.6M Tweet This
£293.6M was invested across Series A rounds in London in December Tweet This
NowRx is disrupting the $480B retail pharmacy industry with unheard of personalized service and free same-day pharmacy delivery. The company uses its “QuickFill” proprietary pharmacy software and robotics to automate prescription dispensing and reduce common service failures that result in bad experiences for customers (insurance errors, out-of-stock, etc.). Oh, and they operate at a fraction of the cost of major retail chains – talk about efficiency! In 2020, the company saw revenue jump 90% YoY and this year they’re on pace to surpass more than $22M in revenue. With their newest telehealth product growing 73% MoM and a share price that has increased by 1,650% since 2016 – this is an investment you don’t want to miss out on. Get in on this rapidly growing startup and learn how you can invest today
The average Series B round in London for December was £21.0M Tweet This
The median Series B round in London for December was £17.5M Tweet This
£168.4M was invested across Series B rounds in London in December Tweet This
NowRx is disrupting the $480B retail pharmacy industry with unheard of personalized service and free same-day pharmacy delivery.
The company uses its “QuickFill” proprietary pharmacy software and robotics to automate prescription dispensing and reduce common service failures that result in bad experiences for customers (insurance errors, out-of-stock, etc.).
Oh, and they operate at a fraction of the cost of major retail chains – talk about efficiency!
In 2020, the company saw revenue jump 90% YoY and this year they’re on pace to surpass more than $22M in revenue. With their newest telehealth product growing 73% MoM and a share price that has increased by 1,650% since 2016 – this is an investment you don’t want to miss out on.
Get in on this rapidly growing startup and learn how you can invest today
The average late-stage round in London for December was £131.3M Tweet This
The median late-stage round in London for December was £69.1M Tweet This
£787.5M was invested across late stage rounds in London in December Tweet This
NowRx is disrupting the $480B retail pharmacy industry with unheard of personalized service and free same-day pharmacy delivery. The company uses its “QuickFill” proprietary pharmacy software and robotics to automate prescription dispensing and reduce common service failures that result in bad experiences for customers (insurance errors, out-of-stock, etc.). Oh, and they operate at a fraction of the cost of major retail chains – talk about efficiency! In 2020, the company saw revenue jump 90% YoY and this year they’re on pace to surpass more than $22M in revenue. With their newest telehealth product growing 73% MoM and a share price that has increased by 1,650% since 2016 – this is an investment you don’t want to miss out on. Get in on this rapidly growing startup and learn how you can invest today
£1.4B was invested in London #startups in December in London across 76 deals Tweet This
London VC funding in December was +22% from last month and +327% from the same period last year Tweet This
NowRx is disrupting the $480B retail pharmacy industry with unheard of personalized service and free same-day pharmacy delivery.
The company uses its “QuickFill” proprietary pharmacy software and robotics to automate prescription dispensing and reduce common service failures that result in bad experiences for customers (insurance errors, out-of-stock, etc.).
Oh, and they operate at a fraction of the cost of major retail chains – talk about efficiency!
In 2020, the company saw revenue jump 90% YoY and this year they’re on pace to surpass more than $22M in revenue. With their newest telehealth product growing 73% MoM and a share price that has increased by 1,650% since 2016 – this is an investment you don’t want to miss out on.
